Vitadio

📍 Praha 2, Czechia🗓 Founded 2019👥 33 employees💰 Last funded Mar 2020
Hospitals and Health Care🌐 vitad.io
Website LinkedIn
Vitadio develops clinically-validated digital therapeutics for type 2 diabetes: a new class of medicine that combines evidence-based approaches with technology to prevent and treat type 2 diabetes at scale. Vitadio is a mobile app that supports patients between doctor’s visits with personalized digital care programmes and scalable support of our team of registered dietitians. We continuously support patients in achieving better health outcomes, provide smart monitoring tools for physicians, and offer a cost-effective solution for health insurers.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Czech Republic
2
Austria
1
Frequently asked questions
Who invested in Vitadio?
Vitadio has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Vitadio last raise funding?
The most recent investment in Vitadio recorded on gritt.io was in March 2020.
When was Vitadio founded?
Vitadio was founded in 2019.
What industry is Vitadio in?
Vitadio operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Vitadio based?
Vitadio is headquartered in Praha 2, Czechia.